Omnicell Inc. (OMCL)
Omnicell (OMCL) Reports Next Week: Wall Street Expects Earnings Growth
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Omnicell Gains 26.2% in a Year: What's Driving the Stock?
OMCL's shares rise on the back of its XT Amplify program gaining market traction with its initial offerings. However, the unfavorable macroeconomic scenario is concerning.
Why Omnicell (OMCL) Might be Well Poised for a Surge
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
What Makes Omnicell (OMCL) a New Strong Buy Stock
Omnicell (OMCL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Omnicell Introduces OmniSphere Platform, Stock to Gain
Omnicell introduces OmniSphere. Additionally, the company showcases a full portfolio of outcomes-centric solutions at the ASHP Midyear 2024.
Why Is Omnicell (OMCL) Down 0.4% Since Last Earnings Report?
Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
Wall Street Analysts Believe Omnicell (OMCL) Could Rally 26.73%: Here's is How to Trade
The mean of analysts' price targets for Omnicell (OMCL) points to a 26.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Here's Why You Should Add OMCL Stock to Your Portfolio Now
A robust Advanced Services portfolio and long-term growth initiatives bode well for Omnicell.
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Omnicell Q3 Earnings: Look At The Growth Segment
Omnicell, Inc. is a pharmacy management provider working towards the goal of an autonomous pharmacy. Q3 earnings looked weak on the surface with revenue and EBITDA down, but results by business show a strong and growing service business. Omnicell has unique technology with strong market tailwinds that support long-term growth.
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
Omnicell continues its trend of impressive results in the third quarter of 2024.
Omnicell, Inc. (OMCL) Soars to 52-Week High, Time to Cash Out?
Omnicell (OMCL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
